Vesamicol binding to subcellular membranes that are distinct from catecholaminergic vesicles in PC12 cells.
We have examined PC12 cells for the localization of binding sites for vesamicol [l-2-(4-phenylpiperidino) cyclohexanol], a compound that has previously been shown to bind to cholinergic vesicles and to inhibit the uptake of acetylcholine. Initial studies presented in this article demonstrate the existence of a specific, saturable vesamicol binding site in PC12 cells. Subsequent experiments show that these binding sites reside in a membrane population that is distinct from catecholamine-containing compartments with respect to density and antigenic composition. In particular, vesamicol binding compartments have a lower density than catecholaminergic vesicles and, unlike these latter vesicles, do not appear to contain the vesicle-specific proteins synaptophysin and SV2 as part of the same membrane. These results suggest that vesicular transport proteins for acetylcholine and catecholamines are differentially sorted to distinct membrane compartments in PC12 cells.
Blumberg
D
D
Neuroscience Training Program, University of Wisoconsin, Madison.
Schweitzer
E S
ES
D000818:Animals; D001665:Binding Sites; D002395:Catecholamines / Q000378:metabolism; D007425:Intracellular Membranes / Q000378:metabolism*; D016716:PC12 Cells / Q000378:metabolism*; D010880:Piperidines / Q000378:metabolism*; D011233:Precipitin Tests; D011506:Proteins / Q000378:metabolism; D013347:Subcellular Fractions / Q000378:metabolism; D014018:Tissue Distribution
D002395:Catecholamines; D010880:Piperidines; D011506:Proteins; C006189:vesamicol